Sorrento Therapeutics Inc

OTC: SRNEQ    
Share price (3/27/24): $0.01    
Market cap (3/27/24): $4.410 million
4 Sorrento Therapeutics Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 45 pages Asset Purchase Agreement by and Between Sorrento Therapeutics, Inc., and Yuhan Corporation Dated as of October 30, 2023
12/34/56
EX-2.1
from 8-K 11 pages Stock Purchase Agreement
12/34/56
EX-2.2
from 8-K 5 pages Mutual Termination and Release Agreement
12/34/56
EX-2.1
from 8-K 20 pages Stock Purchase Agreement by and Between Scilex Holding Company and Sorrento Therapeutics, Inc. September 21, 2023 Stock Purchase Agreement
12/34/56
EX-2.3
from 8-K 5 pages Second Amendment to Stock Purchase Agreement
12/34/56
EX-2.2
from 8-K 3 pages 2. General
12/34/56
EX-2.1
from 8-K 43 pages Stock Purchase Agreement Between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc. August 7, 2023 Stock Purchase Agreement
12/34/56
EX-2.1
from 8-K 7 pages Amendment No.1 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 7 pages Amendment No.1 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 84 pages Agreement and Plan of Merger Dated as of March 17, 2022 by and Among Vickers Vantage Corp. I, Vantage Merger Sub Inc., and Scilex Holding Company
12/34/56
EX-2.1
from 425 84 pages Agreement and Plan of Merger Dated as of March 17, 2022 by and Among Vickers Vantage Corp. I, Vantage Merger Sub Inc., and Scilex Holding Company
12/34/56
EX-2.1
from 8-K 99 pages Agreement and Plan of Merger Among Sorrento Therapeutics, Inc., as Parent Vh Merger Sub I, Inc., as Merger Sub Vh Merger Sub II, LLC, as Merger LLC Virex Health Inc. as the Company and Fortis Advisors LLC as the Stockholders’ Representative Dated as of January 14, 2022 1
12/34/56
EX-2.1
from 8-K 104 pages Agreement and Plan of Merger Among Sorrento Therapeutics, Inc. as Parent at Merger Sub, Inc. as Merger Sub Acea Therapeutics, Inc. as the Company and Fortis Advisors LLC as the Shareholders’ Representative Dated as of April 2, 2021
12/34/56
EX-2.1
from 8-K 87 pages Agreement and Plan of Merger by and Among: Sorrento Therapeutics, Inc., a Delaware Corporation; Sp Merger Sub, Inc., a Delaware Corporation; Smartpharm Therapeutics, Inc., a Delaware Corporation; and John C. Thomas, Jr., as the Stockholders’ Representative Dated as of August 20, 2020
12/34/56
EX-2.2
from 10-Q 3 pages Amendment No. 1 to Agreement and Plan of Merger August 7, 2019
12/34/56
EX-2.1
from 8-K 106 pages Agreement and Plan of Merger by and Among Scilex Holding Company, Sigma Merger Sub, Inc., Semnur Pharmaceuticals, Inc., Fortis Advisors LLC, Solely as the Equityholders’ Representative And, Solely With Respect to Section 1.8(a), Section 3.11 and Article X, Sorrento Therapeutics, Inc. Dated as of March 18, 2019
12/34/56
EX-2.1
from 8-K 104 pages Share Purchase Agreement by and Among Tnk Therapeutics, Inc., Virttu Biologics Limited, the Shareholders of Virttu Biologics Limited, Dayspring Ventures Limited, as the Shareholders’ Representative And, Solely With Respect to Sections 1.2(a), 1.4(b), 1.6, 1.7, 6.6, 6.8, 7.4 and 8.5(a) and Articles V and X, Sorrento Therapeutics, Inc. Dated as of April 27 2017
12/34/56
EX-2.1
from 8-K 97 pages Stock Purchase Agreement by and Among Sorrento Therapeutics, Inc., Scilex Pharmaceuticals Inc., the Stockholders of Scilex Pharmaceuticals Inc., and Spi Shareholders Representative, LLC, as the Stockholders’ Representative Dated as of November 8, 2016
12/34/56
EX-2
from SC 13D 4 pages April 11, 2016 by Hand Delivery, Fedex and Email Board of Directors C/O Sorrento Therapeutics, Inc. 9380 Judicial Drive, San Diego, Ca 92121 Attn: Corporate Secretary Re: Demand for Inspection of Books and Records Dear Sir or Madam
12/34/56
EX-2.1
from 8-K 60 pages Agreement of Merger by and Among: Sorrento Therapeutics, Inc., a Delaware Corporation; Catalyst Merger Sub, Inc., a Delaware Corporation; Concortis Biosystems, Corp., a Delaware Corporation; and Zhenwei Miao and Gang Chen Dated as of November 11, 2013
12/34/56